共 78 条
[1]
Wechalekar AD(2016)Systemic amyloidosis Lancet 387 2641-2654
[2]
Gillmore JD(2013)Amyloidosis: A Clinical Overview Rheum Dis Clin North Am. 39 323-345
[3]
Hawkins PN(2020)The Pathology of Amyloidosis in Classification: A Review Acta Haematol. 143 322-334
[4]
Hazenberg BPC(2021)Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases Eur Heart J. 42 1554-1568
[5]
Picken MM(2018)Cardiac amyloidosis Clin Med (Lond) 18 s30-s35
[6]
Garcia-Pavia P(2021)Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy European J of Heart Fail. 23 895-905
[7]
Martinez-Naharro A(2021)ATTR Amyloidosis: Current and Emerging Management Strategies JACC: CardioOncol. 3 488-505
[8]
Hawkins PN(2020)Diagnostic performance of PET for detection of cardiac amyloidosis: A systematic review and meta-analysis J Cardiol. 76 618-625
[9]
Fontana M(2020)A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research Eur J Epidemiol. 35 49-60
[10]
Garcia-Pavia P(2018)Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement JAMA 319 388-1599